Learn, Analyse & Invest
only with
only with
+91
Download Orca
Fredun Pharmaceuticals Ltd.
Fredun Pharma
₹ 0.00
0.00 (0.00)%
NSE
BSE
Healthcare
Small-cap - With a market cap of ₹12.30 Cr.
| EX-Date | Purpose |
|---|---|
| 28 06 2021 | Audited Results |
| 10 08 2021 | Quarterly Results |
| 06 11 2021 | Quarterly Results |
| 28 01 2022 | Quarterly Results |
| 16 05 2022 | Final Dividend & Audited Results |
| 12 08 2022 | Quarterly Results |
| 27 08 2022 | Preferential Issue of shares |
| 10 11 2022 | Quarterly Results |
| 27 01 2023 | Quarterly Results |
| 24 05 2023 | Final Dividend & Audited Results |
| 19 07 2023 | Quarterly Results |
| 08 11 2023 | Quarterly Results |
| 16 12 2023 | Inter alia consider a proposal for fund raising up to Rs.120 crores by way of further public offer, rights issue, American Depository Receipts/Global Depository Receipts/Foreign Currency Convertible Bonds, qualified institutions placement, debt issue, preferential issue or any other method, in accordance with the provisions of the SEBl (Issue of Capital and Disclosure Requirements) Regulations, 2018 and the Companies Act, 2013 and any other regulations and rules as applicable, as amended subject to such regulatory/ statutory approvals as may be required. |
| 14 02 2024 | Quarterly Results |
| 03 10 2024 | A meeting of the Board of Directors(the Board) of Fredun Pharmaceuticals Limited (the Company) is scheduled to be held on Thursday,03rd October, 2024 to inter alia consider issue and allotment of Unsecured Foreign Currency ConvertibleBonds (FCCBs), in accordance with the provisions of the SEBI (Issue of Capital and DisclosureRequirements) Regulations, 2018 and the Companies Act, 2013 and any other regulations and rules asapplicable, as amended subject to such regulatory/ statutory approvals as may be required. |
| 26 10 2024 | Quarterly Results |
| 04 02 2025 | Quarterly Results |
| 30 05 2025 | Audited Results & Dividend |
| 30 07 2025 | Quarterly Results |
| 25 09 2025 | Preferential Issue of shares & Issue Of Warrants |
| 08 11 2025 | Quarterly Results |
| 09 02 2026 | Quarterly Results |
News
